ATE202109T1 - Kristallines ceftiofur (freie säure) - Google Patents

Kristallines ceftiofur (freie säure)

Info

Publication number: ATE202109T1
Authority: AT; Austria
Prior art keywords: pct; free acid; crystalline ceftiofur; date sep; ceftiofur
Prior art date: 1993-03-12

Application number

AT94910721T

Other languages

English (en)

Inventor

Michael J Dunn

Michael S Bergren

Gregory E Hardee

Kenneth Paul Shephard

Robert S Chao

Jeffrey L Havens

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-12

Filing date

1994-03-07

Publication date

2001-06-15

1994-03-07 Application filed by Upjohn Co filed Critical Upjohn Co

2001-06-15 Application granted granted Critical

2001-06-15 Publication of ATE202109T1 publication Critical patent/ATE202109T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT94910721T 1993-03-12 1994-03-07 Kristallines ceftiofur (freie säure) ATE202109T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3329193A	1993-03-12	1993-03-12
PCT/US1994/001862 WO1994020505A1 (en)	1993-03-12	1994-03-07	Crystalline ceftiofur free acid

Publications (1)

Publication Number	Publication Date
ATE202109T1 true ATE202109T1 (de)	2001-06-15

Family

ID=21869579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94910721T ATE202109T1 (de)	1993-03-12	1994-03-07	Kristallines ceftiofur (freie säure)

Country Status (31)

Country	Link
US (1)	US5721359A (de)
EP (1)	EP0690864B1 (de)
JP (1)	JP3852946B2 (de)
KR (1)	KR100296810B1 (de)
CN (1)	CN1055090C (de)
AT (1)	ATE202109T1 (de)
AU (1)	AU694419B2 (de)
BR (1)	BR1101034A (de)
CA (1)	CA2155322C (de)
CZ (1)	CZ289332B6 (de)
DE (2)	DE122005000055I2 (de)
DK (1)	DK0690864T3 (de)
ES (1)	ES2157254T3 (de)
FI (1)	FI120307B (de)
FR (1)	FR05C0045I2 (de)
GR (1)	GR3036514T3 (de)
HU (1)	HU222244B1 (de)
IL (1)	IL108910A (de)
LU (1)	LU91206I2 (de)
LV (1)	LV12889B (de)
NL (1)	NL300208I2 (de)
NO (2)	NO313199B1 (de)
NZ (1)	NZ263002A (de)
PL (1)	PL184611B1 (de)
PT (1)	PT690864E (de)
RU (1)	RU2136685C1 (de)
SI (1)	SI0690864T1 (de)
SK (1)	SK283674B6 (de)
TW (1)	TW267170B (de)
WO (1)	WO1994020505A1 (de)
ZA (1)	ZA941586B (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5736151A (en) *	1996-12-09	1998-04-07	Pharmacia & Upjohn Company	Antibiotic oil suspensions
US6074657A (en) *	1997-03-20	2000-06-13	Pharmacia & Upjohn Company	Administration of an injectable antibiotic in the ear of an animal
US7829100B2 (en) *	2000-09-12	2010-11-09	Teagarden Dirk L	Pharmaceutical composition having modified carrier
WO2002022107A2 (en) *	2000-09-12	2002-03-21	Pharmacia & Upjohn Company	Pharmaceutical composition having modified carrier
KR100423895B1 (ko) *	2001-02-19	2004-03-24	주식회사 엘지생명과학	셉티오퍼 하이드로클로라이드의 현탁제 조성물
US20030109525A1 (en) *	2001-07-10	2003-06-12	Pharmacia & Upjohn Company	Crystalline thiazine oxazolidinones
BR0211612A (pt)	2001-08-15	2004-08-24	Upjohn Co	Cristais que incluem um sal de ácido málico de n-[2-(dietilamino)etil]-5-[(5-flúor2-oxo-3h-indol-3-ilide no)metil]-2,4-dimetil-1h-pirrol-3-carboxamida, processos para a sua preparação e suas composições
DE60309447T3 (de) †	2002-03-21	2020-04-23	Zoetis Services LLC (n.d.Ges.d.Staates Delaware)	Verfahren zur verabreichung von injizierbarem antibiotikum in dem ohr eines tieres
US20040022815A1 (en) *	2002-08-05	2004-02-05	Orchid Health Care	Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) *	2002-08-13	2004-02-19	대한뉴팜(주)	세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US20040115822A1 (en) *	2002-09-12	2004-06-17	Schapaugh Randal Lee	Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7659061B2 (en) *	2002-11-19	2010-02-09	Pharmacia & Upjohn Company	Pharmaceutical compositions having a modified vehicle
US20040115837A1 (en) *	2002-11-27	2004-06-17	Schapaugh Randal Lee	Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7842791B2 (en) *	2002-12-19	2010-11-30	Nancy Jean Britten	Dispersible pharmaceutical compositions
PL1606293T3 (pl) *	2003-03-27	2010-01-29	Basilea Pharmaceutica Ag	Cefalosporyna w postaci krystalicznej
RU2359670C2 (ru)	2004-03-25	2009-06-27	Астеллас Фарма Инк.	Композиция солифенацина или его соли для использования в твердом препарате
US7815939B2 (en)	2005-07-20	2010-10-19	Astellas Pharma Inc.	Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
BRPI0617561A2 (pt) *	2005-10-12	2011-08-23	Orchid Chemicals & Pharm Ltd	sal de sódio cristalino antibiótico de cefalosporina
US8470809B2 (en) *	2005-10-12	2013-06-25	Orchid Chemicals & Pharmaceuticals Limited	Crystalline sodium salt of cephalosporin antibiotic
ES2442926T3 (es)	2007-08-22	2014-02-14	Astrazeneca Ab	Derivados de ciclopropilamida `978
EP2303026B1 (de)	2008-06-17	2020-09-09	Brigham Young University	Antimikrobielle diagnose-, erkennungs-, screening- und abbildungsverfahren mit kationischen steroiden
WO2010020871A2 (en) *	2008-08-22	2010-02-25	Orchid Chemicals & Pharmaceuticals Limited	Crystalline sodium salt of cephalosporin antibiotic
AU2009316708B2 (en) *	2008-11-19	2014-07-17	Boehringer Ingelheim Animal Health USA Inc.	Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
US20110288142A1 (en) *	2009-01-30	2011-11-24	Chen Pingyun Y	CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en)	2009-02-20	2010-11-16	Astrazeneca Ab	Cyclopropyl amide derivatives 983
CN103140481A (zh) *	2010-02-18	2013-06-05	阿斯利康(瑞典)有限公司	包含环丙基酰胺衍生物的固体形式
SG183274A1 (en) *	2010-02-18	2012-09-27	Astrazeneca Ab	Processes for making cyclopropyl amide derivatives and intermediates associated therewith
WO2012150520A1 (en) *	2011-05-02	2012-11-08	Pfizer Inc.	Novel cephalosporins useful as antibacterial agents
CA2842462C (en)	2011-07-20	2020-01-28	Brigham Young University	Hydrogel materials incorporating eluting ceragenin compound
US9603859B2 (en)	2011-09-13	2017-03-28	Brigham Young University	Methods and products for increasing the rate of healing of tissue wounds
JP6038155B2 (ja)	2011-09-13	2016-12-07	ブリガム・ヤング・ユニバーシティＢｒｉｇｈａｍＹｏｕｎｇＵｎｉｖｅｒｓｉｔｙ	組織創傷を治癒させる製品
JP6038154B2 (ja)	2011-09-13	2016-12-07	ブリガム・ヤング・ユニバーシティＢｒｉｇｈａｍＹｏｕｎｇＵｎｉｖｅｒｓｉｔｙ	骨疾患および破断骨治療のための組成物
US9694019B2 (en)	2011-09-13	2017-07-04	Brigham Young University	Compositions and methods for treating bone diseases and broken bones
KR20140116111A (ko)	2011-12-21	2014-10-01	브라이엄 영 유니버시티	구강 관리 조성물
CN102584855B (zh) *	2012-02-16	2014-06-25	青岛科技大学	一种改进的头孢噻呋的制备方法
US9533063B1 (en)	2012-03-01	2017-01-03	Brigham Young University	Aerosols incorporating ceragenin compounds and methods of use thereof
WO2013165574A2 (en)	2012-05-02	2013-11-07	Brigham Young University	Ceragenin particulate materials and methods for making same
EP2908826A1 (de)	2012-10-17	2015-08-26	Brigham Young University	Behandlung und prävention von mastitis
JP6310396B2 (ja) *	2012-12-03	2018-04-11	株式会社カネカ	還元型補酵素ｑ１０誘導体およびその製造方法
CA2897150C (en)	2013-01-07	2021-07-13	Brigham Young University	Methods for reducing cellular proliferation and treating certain diseases
US11524015B2 (en)	2013-03-15	2022-12-13	Brigham Young University	Methods for treating inflammation, autoimmune disorders and pain
US10568893B2 (en)	2013-03-15	2020-02-25	Brigham Young University	Methods for treating inflammation, autoimmune disorders and pain
CA2907082C (en)	2013-03-15	2021-05-04	Brigham Young University	Methods for treating inflammation, autoimmune disorders and pain
RU2546675C2 (ru) *	2013-04-11	2015-04-10	Федеральное казённое предприятие "Государственный научно-исследовательский институт химических продуктов" (ФКП "ГосНИИХП")	Способ определения степени кристалличности составов на основе дифениламина
US9387215B2 (en)	2013-04-22	2016-07-12	Brigham Young University	Animal feed including cationic cholesterol additive and related methods
KR20230159631A (ko) *	2013-09-05	2023-11-21	미쓰비시 타나베 파마 코퍼레이션	신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법
US11690855B2 (en)	2013-10-17	2023-07-04	Brigham Young University	Methods for treating lung infections and inflammation
US20150203527A1 (en)	2014-01-23	2015-07-23	Brigham Young University	Cationic steroidal antimicrobials
CA2844321C (en)	2014-02-27	2021-03-16	Brigham Young University	Cationic steroidal antimicrobial compounds
US10220045B2 (en)	2014-03-13	2019-03-05	Brigham Young University	Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en)	2014-03-13	2018-01-16	Brigham Young University	Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en)	2014-03-14	2018-04-03	Brigham Young University	Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en)	2014-04-30	2017-06-27	Brigham Young University	Methods and apparatus for cleaning or disinfecting a water delivery system
US10238665B2 (en)	2014-06-26	2019-03-26	Brigham Young University	Methods for treating fungal infections
US10441595B2 (en)	2014-06-26	2019-10-15	Brigham Young University	Methods for treating fungal infections
US10227376B2 (en)	2014-08-22	2019-03-12	Brigham Young University	Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en)	2014-10-07	2018-12-18	Brigham Young University	Cationic steroidal antimicrobial prodrug compositions and uses thereof
EP3760618A1 (de) *	2014-10-21	2021-01-06	ARIAD Pharmaceuticals, Inc.	Kristalline formen von 5-chlor-n4-[-2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrimidin-2,4-diamin
WO2016172543A1 (en)	2015-04-22	2016-10-27	Savage Paul B	Methods for the synthesis of ceragenins
US9527883B2 (en)	2015-04-22	2016-12-27	Brigham Young University	Methods for the synthesis of ceragenins
KR101753842B1 (ko) *	2015-05-12	2017-07-04	한국화학연구원	불화퀴놀론계 항생제를 담지한 서방형 제제 및 이의 제조방법
US9434759B1 (en)	2015-05-18	2016-09-06	Brigham Young University	Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
CN106543203B (zh) *	2015-09-18	2019-07-02	瑞普（天津）生物药业有限公司	一种长效头孢噻呋自由酸晶体的制备方法
AU2017208574B2 (en) *	2016-01-22	2022-09-22	Sandoz Ag	Crystalline eravacycline bis-hydrochloride
US10226550B2 (en)	2016-03-11	2019-03-12	Brigham Young University	Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
KR101898282B1 (ko) *	2016-05-24	2018-09-13	주식회사 고려비엔피	항생제의 서방형 수의학적 조성물 및 이의 제조방법
MX2019000115A (es)	2016-07-07	2019-04-22	Ironwood Pharmaceuticals Inc	Formas solidas de un estimulador de gualinato ciclasa soluble (sgc).
US10959433B2 (en)	2017-03-21	2021-03-30	Brigham Young University	Use of cationic steroidal antimicrobials for sporicidal activity
US11186556B1 (en) *	2018-10-16	2021-11-30	Celgene Corporation	Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk)	2018-12-20	2019-07-25	Анатолій Семенович Редер	Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
US12186328B2 (en)	2019-05-23	2025-01-07	Brigham Young University	Use of CSA compounds to stimulate stem cells and hair growth
TW202233625A (zh) *	2020-11-18	2022-09-01	美商傳達治療有限公司	Ｆｇｆｒ抑制劑及其製造及使用方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1207933B (de) *	1962-12-26	1965-12-30	American Home Prod	Verfahren zur Herstellung von kristallwasser-freiem D-alpha-Aminobenzylpenicillin
US3489750A (en) *	1967-09-05	1970-01-13	Bristol Myers Co	7-amino-cephalosporanic and decephalosporanic acid derivatives
DK154939C (da) *	1974-12-19	1989-06-12	Takeda Chemical Industries Ltd	Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) *	1976-01-23	1986-04-30	Roussel-Uclaf, Paris	7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GB1532682A (en) *	1976-04-27	1978-11-22	Bristol Myers Co	Process for the preparation of cephadroxil
FR2479229B1 (fr) *	1980-03-26	1986-01-17	Clin Midy	Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
IL63968A (en) *	1980-10-01	1985-10-31	Glaxo Group Ltd	Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4400503A (en) *	1981-10-30	1983-08-23	Eli Lilly And Company	Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
DE3313818A1 (de) *	1983-04-16	1984-10-18	Hoechst Ag, 6230 Frankfurt	Neue kristallmodifikation von ceftazidim
HU196714B (en) *	1984-10-04	1989-01-30	Monsanto Co	Process for producing non-aqueous composition comprising somatotropin
US4902683A (en) *	1984-10-25	1990-02-20	The Upjohn Company	Crystalline cephalosporin hydrohalide salts
IT1181672B (it) *	1984-10-25	1987-09-30	Upjohn Co	Cefalosporina alogenidrato cristallino
DE3650526T2 (de) *	1985-08-12	1996-10-31	Upjohn Co	Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz
GB8608962D0 (en) *	1986-04-12	1986-05-14	Beecham Group Plc	Beta-lactam antibiotics
IT1214587B (it) *	1986-12-23	1990-01-18	Giovanni Bonfanti	Metodo per la produzione diprodotti cristallini puri.
ATE76874T1 (de) *	1987-02-02	1992-06-15	Lilly Co Eli	Verfahren zur herstellung von ceftazidimepentahydrat.
DE3869135D1 (de) *	1987-07-29	1992-04-16	Upjohn Co	Kontrollierte freisetzung von antibiotika-salzen aus einem implantat.
AU617377B2 (en) *	1987-11-10	1991-11-28	Pharmacia & Upjohn Company	Cephalosporin antibiotics
US4877782A (en) *	1988-02-16	1989-10-31	The Upjohn Company	Zinc ceftiofur complexes

1994
- 1994-03-07 AT AT94910721T patent/ATE202109T1/de active
- 1994-03-07 CZ CZ19952290A patent/CZ289332B6/cs unknown
- 1994-03-07 RU RU95121942A patent/RU2136685C1/ru active
- 1994-03-07 PT PT94910721T patent/PT690864E/pt unknown
- 1994-03-07 AU AU63510/94A patent/AU694419B2/en not_active Expired
- 1994-03-07 HU HU9501960A patent/HU222244B1/hu active Protection Beyond IP Right Term
- 1994-03-07 WO PCT/US1994/001862 patent/WO1994020505A1/en active IP Right Grant
- 1994-03-07 PL PL94310556A patent/PL184611B1/pl unknown
- 1994-03-07 ES ES94910721T patent/ES2157254T3/es not_active Expired - Lifetime
- 1994-03-07 DE DE122005000055C patent/DE122005000055I2/de active Active
- 1994-03-07 DK DK94910721T patent/DK0690864T3/da active
- 1994-03-07 NZ NZ263002A patent/NZ263002A/en not_active IP Right Cessation
- 1994-03-07 ZA ZA941586A patent/ZA941586B/xx unknown
- 1994-03-07 SK SK1114-95A patent/SK283674B6/sk not_active IP Right Cessation
- 1994-03-07 CA CA002155322A patent/CA2155322C/en not_active Expired - Lifetime
- 1994-03-07 SI SI9430374T patent/SI0690864T1/xx unknown
- 1994-03-07 KR KR1019950703858A patent/KR100296810B1/ko not_active IP Right Cessation
- 1994-03-07 DE DE69427469T patent/DE69427469T2/de not_active Expired - Lifetime
- 1994-03-07 EP EP94910721A patent/EP0690864B1/de not_active Expired - Lifetime
- 1994-03-07 US US08/549,821 patent/US5721359A/en not_active Expired - Lifetime
- 1994-03-07 JP JP52002594A patent/JP3852946B2/ja not_active Expired - Lifetime
- 1994-03-07 CN CN94191448A patent/CN1055090C/zh not_active Expired - Lifetime
- 1994-03-09 IL IL10891094A patent/IL108910A/en not_active IP Right Cessation
- 1994-03-12 TW TW083102155A patent/TW267170B/zh not_active IP Right Cessation
1995
- 1995-09-11 NO NO19953564A patent/NO313199B1/no not_active IP Right Cessation
- 1995-09-11 FI FI954250A patent/FI120307B/fi not_active IP Right Cessation
1997
- 1997-05-14 BR BR1101034-7A patent/BR1101034A/pt active IP Right Grant
2001
- 2001-09-04 GR GR20010401374T patent/GR3036514T3/el unknown
2002
- 2002-06-13 LV LVP-02-107A patent/LV12889B/lv unknown
2005
- 2005-11-16 LU LU91206C patent/LU91206I2/fr unknown
- 2005-11-17 FR FR05C0045C patent/FR05C0045I2/fr active Active
- 2005-11-18 NO NO2005025C patent/NO2005025I2/no unknown
- 2005-11-21 NL NL300208C patent/NL300208I2/nl unknown

Also Published As

Publication number	Publication date
NO313199B1 (no)	2002-08-26
BR1101034A (pt)	2002-04-30
KR100296810B1 (ko)	2001-10-24
TW267170B (de)	1996-01-01
CZ9502290A3 (cs)	2001-08-15
FI954250A (fi)	1995-09-11
SK283674B6 (sk)	2003-11-04
FR05C0045I2 (de)	2007-08-03
HU222244B1 (hu)	2003-05-28
DK0690864T3 (da)	2001-09-17
PT690864E (pt)	2001-11-30
NL300208I1 (nl)	2006-02-01
CZ289332B6 (cs)	2002-01-16
HUT73781A (en)	1996-09-30
JP3852946B2 (ja)	2006-12-06
LU91206I2 (fr)	2006-05-30
NL300208I2 (nl)	2006-05-01
CA2155322A1 (en)	1994-09-15
RU2136685C1 (ru)	1999-09-10
JPH08507519A (ja)	1996-08-13
LV12889B (lv)	2002-12-20
HU9501960D0 (en)	1995-09-28
NO2005025I1 (no)	2005-12-05
GR3036514T3 (en)	2001-12-31
US5721359A (en)	1998-02-24
EP0690864A1 (de)	1996-01-10
FR05C0045I1 (de)	2006-01-06
AU694419B2 (en)	1998-07-23
IL108910A0 (en)	1994-06-24
ES2157254T3 (es)	2001-08-16
IL108910A (en)	1999-10-28
CN1119016A (zh)	1996-03-20
NZ263002A (en)	1996-12-20
CN1055090C (zh)	2000-08-02
CA2155322C (en)	2000-02-29
NO953564D0 (no)	1995-09-11
ZA941586B (en)	1995-09-07
NO953564L (no)	1995-11-07
NO2005025I2 (no)	2010-11-22
PL184611B1 (pl)	2002-11-29
FI954250A0 (fi)	1995-09-11
SK111495A3 (en)	1995-12-06
DE69427469D1 (en)	2001-07-19
WO1994020505A1 (en)	1994-09-15
EP0690864B1 (de)	2001-06-13
PL310556A1 (en)	1995-12-27
DE69427469T2 (de)	2001-10-31
DE122005000055I2 (de)	2008-06-05
DE122005000055I1 (de)	2006-02-23
FI120307B (fi)	2009-09-15
AU6351094A (en)	1994-09-26
SI0690864T1 (en)	2001-10-31

Publication	Publication Date	Title
ATE202109T1 (de)	2001-06-15	Kristallines ceftiofur (freie säure)
FI952900A0 (fi)	1995-06-13	Polypeptidi ja siitä valmistettu anti-HIV-aine
IL108520A0 (en)	1994-05-30	Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
IL111861A0 (en)	1995-03-15	N-substituted azabicycloalkane derivatives
IL109448A0 (en)	1994-07-31	Risperidone pamoate, its preparation and pharmaceutical compositions containing it
AU6303996A (en)	1997-01-22	Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders
TW252979B (de)	1995-08-01
IL107520A0 (en)	1994-02-27	Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
TW261605B (de)	1995-11-01
AU1067295A (en)	1995-06-19	Substituted aminoalkylaminopyridines
NO952926D0 (no)	1995-07-24	Fremgangsmåte for fremstilling av C-substituerte dietylentriaminer
ES8606272A1 (es)	1986-04-01	Procedimiento para preparar derivados carboxialquildipepti- dicos
GR3002538T3 (en)	1993-01-25	Crystal modification of 3-methoxy-4-(4'-amino benzolsulfonamido)-1,2,5-thiadiazole, process for its production and pharmaceutical compositions containing it